Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-16

FDA Approved: CYTALUX — Supplemental Application (On Target Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CYTALUX (pafolacianine injection) by On Target Laboratories, expanding the product's labeling. The expansion relates…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cytalux (pafolacianine)

Snippet

SUPPL AP for CYTALUX (PAFOLACIANINE INJECTION)